Primary Renal Cortical Epithelial Cells; Normal, Human (HRCE) (ATCC^® PCS-400-011^™)

1. Obtain one Renal Epithelial Cell Growth Kit from the freezer; make sure that the caps of all components are tight.
2. Thaw the components of the growth kit just prior to adding them to the basal medium.
3. Obtain one bottle of Renal Epithelial Cell Basal Medium (485 mL) from cold storage.
4. Decontaminate the external surfaces of all growth kit component vials and the basal medium bottle by spraying them with 70% ethanol.
5. Using aseptic technique and working in a laminar flow hood or biosafety cabinet, transfer the indicated volume of each growth kit component, as indicated in Table 1, to the bottle of basal medium using a separate sterile pipette for each transfer.

Table 1. Renal Epithelial Cell Growth Kit Components 

Component	Volume	Final Concentration
Fetal Bovine Serum (FBS)	2.5 mL	0.5%
Triiodothyronine	0.5 mL	10 nM
rh EGF	1.0 mL	10 ng/mL
Hydrocortisone Hemisuccinate	0.5 mL	100 ng/mL
rh Insulin	0.5 mL	5 µg/mL
Epinephrine	0.5 mL	1.0 µM
Transferrin	0.5 mL	5 µg/mL
L-Alanyl-L-Glutamine	6.0 mL	2.4 mM

 

Antimicrobials and phenol red are not required for proliferation but may be added if desired. The recommended volume of either of the optional components to be added to the complete growth media is summarized in Table 2.

Table 2. Addition of Antimicrobials/Antimycotics and Phenol Red (Optional)

Component	Volume	Final Concentration
Penicillin-Streptomycin-Amphotericin B Solution	0.5 mL	Penicillin: 10 Units/mL Streptomycin: 10 µg/mL Amphotericin B: 25 µg/mL
Phenol Red	0.5 mL	33 µM

1. Passage normal renal cortical cells when the culture has reached approximately 95% confluence.
2. Warm both the Trypsin-EDTA for Primary Cells (ATCC PCS-999-003) and the Trypsin Neutralizing Solution (ATCC PCS-999-004) to room temperature prior to dissociation. Warm the complete growth medium to 37°C prior to use with the cells.
3. For each flask, carefully aspirate the spent media without disturbing the monolayer.
4. Rinse the cell layer one time with 3 to 5 mL D-PBS (ATCC 30-2200) to remove residual medium.
5. Add pre-warmed trypsin-EDTA solution (1 to 2 mL for every 25 cm²) to each flask.
6. Gently rock each flask to ensure complete coverage of the trypsin-EDTA solution over the cells, and then aspirate the excess fluid off of the monolayer.
7. Observe the cells under the microscope. When the cells pull away from each other and round up (typically within 1 to 3 minutes), remove the flask from the microscope and gently tap it from several sides to promote detachment of the cells from the flask surface.
8. When the majority of cells appear to have detached, quickly add an equal volume of the Trypsin Neutralizing Solution (ATCC PCS-999-004) to each flask. Gently pipette or swirl the culture to ensure all of the trypsin-EDTA solution has been neutralized.
9. Transfer the dissociated cells to a sterile centrifuge tube and set aside while processing any remaining cells in the culture flask. 
10. Add 3 to 5 mL D-PBS (ATCC 30-2200) to the tissue culture flask to collect any additional cells that might have been left behind. 
11. Transfer the cell/D-PBS suspension to the centrifuge tube containing the trypsin-EDTA-dissociated cells.
12. Repeat steps 10 and 11 as needed until all cells have been collected from the flask. 
13. Centrifuge the cells at 150 x g for 3 to 5 minutes . 
14. Aspirate neutralized dissociation solution from the cell pellet and resuspend the cells in 2 to 8 mL fresh, pre-warmed, complete growth medium. 
15. Count the cells and seed new culture flasks at a density of 5,000 viable cells per cm². 
16. Place newly seeded flasks in a 37°C, 5% CO₂ incubator for at least 24 to 48 hours before processing the cells further. Refer to Maintenance for guidelines on feeding.

Wu J, Wang Z. Osteopontin Improves Adhesion and Migration of Human Primary Renal Cortical Epithelial Cells During Wound Healing. Oncol Lett 6(12):4556-60, 2016. PubMed: 28101213

Shin Y, et al. Regulation of KLF12 by microRNA-20b and microRNA-106a in Cystogenesis. FASEB J 32(7):3574-3582, 2018. PubMed: 29475398

Lee EJ, et al. Blockade of Interleukin-8 Receptor Signalling Inhibits Cyst Development in Vitro, Via Suppression of Cell Proliferation in Autosomal Polycystic Kidney Disease. Nephrology (Carlton) 8(19):471-8, 2014. PubMed: 24724588

Aronin A, et al. Highly Efficient, in-Vivo Fas-Mediated Apoptosis of B-Cell Lymphoma by Hexameric Ctla4-Fasl. J Hematol Oncol 7(7):64, 2014. PubMed: 25227919

Laberge RM, et al. Treatment for osteoarthritis by intra-articular administration of cis-imidazoline. United States Patent Pat. No.: US 9,855,266 B2, 2018.

Laberge RM, et al. Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells. United States Patent Pat. No.: US 9,849,128 B2, 2017.